2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
2022/04/01 by Paul A. Heidenreich, Biykem Bozkurt, David Aguilar +27 · 1 citation
Engineering · Medicine · #Alternative medicine #Cardiac Structural Anomalies and Repair #Cardiology #Disease management #Evidence-based medicine #Guideline #Health management system #Heart Failure Treatment and Management #Heart failure #Intensive care medicine #MEDLINE #Management of heart failure #Mechanical Circulatory Support Devices #Medicine #Pathology #Systematic review
paper · doi:10.1016/j.jacc.2021.12.012
openalex publication_date 2022/04/01 · crossref created 2022/04/01 · openalex created_date 2022/04/03 · crossref issued 2022/05/01 · crossref published 2022/05/01 · crossref published-print 2022/05/01 · crossref deposited 2023/11/19 · openalex updated_date 2026/08/05 · crossref indexed 2026/08/05
Citations
- Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
- An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea
- Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function
- Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease
- Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan
- Transitional Care Interventions to Prevent Readmissions for Persons With Heart Failure
- Pengaruh Jumlah Pemakaian Hidrogen Peroksida (H2O2) Pada Tahap EP2 Terhadap Brightness Pulp Di Unit Bleaching PT. Toba Pulp Lestari, Tbk Porsea
- Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial
- Trescientos años de la Biblioteca Nacional: "En la era digital su principal objetivo sigue siendo la preservación del patrimonio bibliográfico español"
- Major Congenital Malformations after First-Trimester Exposure to ACE Inhibitors
- Increased Mortality and Cardiovascular Morbidity Associated With Use of Nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
- 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
- Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis
- The Use of Digoxin in Patients With Worsening Chronic Heart Failure
- Repeated hospitalizations predict mortality in the community population with heart failure
- Do Self-Management Interventions Work in Patients With Heart Failure?
- Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- Defining Advance Care Planning for Adults: A Consensus Definition From a Multidisciplinary Delphi Panel
- Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
- Pathophysiology of Takotsubo Syndrome
- Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction
- Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
- Cancer statistics, 2018
- Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device
- The Role of the Clinical Examination in Patients With Heart Failure
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association
- Socioeconomic Status and Cardiovascular Outcomes
- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
- 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
- How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
- Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- Structured telephone support or non-invasive telemonitoring for patients with heart failure
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
- 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
- Heart Disease and Stroke Statistics—2021 Update
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- The Transfer of Drugs and Other Chemicals Into Human Milk
- Obesity and the Obesity Paradox in Heart Failure
- Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
Cited by